EUVIMEDEUVIMED entdecken
Crossref

Broadening the horizon of immune thrombocytopenia through Omics approaches

Rick Kapur iD

British Journal of Haematology · 2024-06 · 204 (6) · 2159-2161

DOI: 10.1111/bjh.19514 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Haematology, online erschienen am 08.05.2024. Verfasst von Rick Kapur. Beteiligte Einrichtung: Sanquin Research, Department of Experimental Immunohematology, Amsterdam and Landsteiner Laboratory, Amsterdam UMC, University of Amsterdam, Amsterda…. Hauptthemen laut MEDLINE: Purpura, Thrombocytopenic, Idiopathic, Proteomics, Metabolomics. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 9 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Immune thrombocytopenia (ITP) is a highly heterogeneous autoimmune bleeding disorder characterized by low platelet counts due to an immune‐mediated platelet destruction and impaired platelet production. The pathophysiology is multifactorial and remains to be fully unravelled. Consequently, disease trajectories and responses to therapeutics, despite the availability of multiple agents, can be unpredictable and differing between patients. There is an urgent need for the identification of diagnostic and therapeutic biomarkers, but this has proven to be challenging to achieve. To shed light on this, two studies in this issue of the British Journal of Haematology have recognized the opportunity of using high‐throughput Omics technologies in ITP. Sun et al. performed proteomics, and Li et al. metabolomics, on bone marrow biopsy samples of patients with ITP. This was conducted using mass spectrometry and, due to the generation of large datasets, in combination with machine learning. These studies set the stage for further investigations exploring the high potential of multi‐omics technologies in order to shed light on the heterogeneity in ITP, accelerating the path towards a much needed personalized medicine approach. Commentary on: Li et al. Metabolomics profile and machine learning prediction of treatment responses in immune thrombocytopenia: A prospective cohort study. Br J Haematol 2024;204:2405‐2417. Commentary on: Sun et al. Proteomics landscape and machine learning prediction of long‐term response to splenectomy in primary immune thrombocytopenia. Br J Haematol 2024;204:2418‐2428.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Purpura, Thrombocytopenic, IdiopathicProteomicsMetabolomicsHumansBiomarkersMachine Learning

Stichwörter der Autor:innen

immune thrombocytopeniamachine learningmetabolomicsomicsproteomics

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Sanquin Research, Department of Experimental Immunohematology, Amsterdam and Landsteiner Laboratory, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.

ORCID-Profile: Rick Kapur

Zitieren

APA

Kapur, R. (2024). Broadening the horizon of immune thrombocytopenia through Omics approaches. British Journal of Haematology, 204(6), 2159-2161. https://doi.org/10.1111/bjh.19514

Vancouver

Kapur R. Broadening the horizon of immune thrombocytopenia through Omics approaches. British Journal of Haematology. 2024;204(6):2159-2161. doi:10.1111/bjh.19514

BibTeX
@article{Kapur2024,
  author = {Kapur, Rick},
  title = {Broadening the horizon of immune thrombocytopenia through Omics approaches},
  journal = {British Journal of Haematology},
  year = {2024},
  volume = {204},
  number = {6},
  pages = {2159--2161},
  doi = {10.1111/bjh.19514}
}
Kostenlos starten →